More Avecho Biotechnology Limited news
Avecho Biotechnology LimitedASX: AVE

September 2025 Quarterly Activities Report & Appendix 4C

Oct 31, 2025 at 2:16 AM EDT · Issued by Avecho Biotechnology Limited

Filed with ASX · Oct 31, 2025 at 2:16 AM EDT

On 6ix: 6ix.com/news/september-2025-quarterly-activities-report-and-appendix-4c-5

Avecho Biotechnology Ltd has released a press release.

View Attachment

6ix hasn’t read this filing yet.

Avecho Biotechnology Limited on 6ix

Story so far

  • Appendix 4D and Half-year Financial ReportAug 28, 2025
  • June 2025 Quarterly Activities Report & Appendix 4CJul 30, 2025
  • March 2025 Quarterly Activities Report & Appendix 4CApr 30, 2025

Earlier from Avecho Biotechnology

  • Avecho raises $2.5m via placementOct 22, 2025
  • Appendix 4D and Half-year Financial ReportAug 28, 2025
  • Sleep Health Week: Researchers Recruiting Now for CBD Insomnia TrialAug 11, 2025
  • June 2025 Quarterly Activities Report & Appendix 4CJul 29, 2025
  • Phase III Insomnia Trial Recruitment UpdateJul 28, 2025

Later from Avecho Biotechnology

  • AVE Secures US & EU Patent Allowances for CBD Soft-GelDec 3, 2025
  • Phase III CBD Clinical Trial Recruitment UpdateDec 17, 2025
  • December 2025 Quarterly Activities Report & Appendix 4CJan 29
  • Annual Report 31 December 2025Feb 27
  • Avecho completes recruitment for Phase III interim analysisMar 1
All Avecho Biotechnology news releases↗

Follow Avecho Biotechnology into a list and get an email when it puts out news.

Follow Avecho Biotechnology
  • About 6ix
  • Editorial & Sourcing
  • Corrections
  • Contact
  • Privacy
  • Terms
  • Disclaimer